


Regeneron Pharmaceuticals, Inc. today announced financial and operating results for the second quarter of 2010. The Company reported a net loss of $25.5 million, or $0.31 per share (basic and diluted), for the second quarter of 2010 compared with a net loss of $14.9 million, or $0.19 per share (basic and diluted), for the second quarter of 2009.
Read more...Jessiah Jackson was running around, doing everything typical of a 17-month-old boy. There was no sign that a day before he had a metal rod lodged into his brain.
Read more...High-Tech 'Bots in Medicine and the Military Are Still in the Model T Stage of Robotic Science
Read more...